Clinical Trial Update: A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study evaluating intravitreal BS01 for geographic atrophy secondary to dry age-related macular degeneration, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• BS01

Snippet

Sponsor: Bionic Sight LLC | Conditions: Geographic Atrophy (GA) Secondary to Dry Age-related Macular Degeneration (AMD) | Phase 1, Phase 2 | Status: RECRUITING